Hims & Hers Health, Inc.
Hims & Hers Health, Inc. scores highest on Earnings (75) and lowest on Price (3). Its PosiPenta is 41.96 out of 100, around the middle of similar companies.
On the Penta Grid this week, Hims & Hers Health, Inc. is Grid #470 of 837 in the Healthcare sector in United States, and Grid #2,695 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Hims & Hers Health, Inc. | 41.96 | 3 | 75 | 53 | 32 | 47 |
| Chemed Corporation | 66.89 | 33 | 73 | 91 | 64 | 73 |
| Lantheus Holdings, Inc. | 61.65 | 41 | 75 | 90 | 62 | 40 |
| Amneal Pharmaceuticals, Inc. | 61.30 | 14 | 83 | 91 | 50 | 68 |
| Iovance Biotherapeutics, Inc. | 53.82 | 8 | 62 | 92 | 55 | 53 |
| Praxis Precision Medicines, Inc. | 40.95 | 13 | 24 | 62 | 69 | 36 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -43.86 |
| P/B ratio | 20.21 |
EEarnings
| Trailing EPS | ₹-60.62 |
| Forward EPS | ₹69.83 |
NNitro
| Price | 2658.65 |
| 52-week high | 5441.37 |
| 52-week low | 1301.38 |
| Fall from 52-week high | 51.1% |
TTorque
| Return on equity (ROE) | -32.03% |
| Debt-to-equity | 4.77 |
AAnchor
| Beta (price swings) | 2.43 |
| Market cap | ₹62,029 Cr |
| Insider holding | 4.95% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Hims & Hers Health, Inc.'s PosiPenta score?
Hims & Hers Health, Inc.'s PosiPenta is 41.96 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Hims & Hers Health, Inc. stand on the Penta Grid?
On the Penta Grid this week, Hims & Hers Health, Inc. is Grid #470 of 837 in the Healthcare sector in United States, and Grid #2,695 of 4,000 in United States.
Which PosiPenta pillar is strongest for Hims & Hers Health, Inc.?
Earnings (growth), with a score of 75 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Hims & Hers Health, Inc.?
Price (valuation), with a score of 3 out of 100: much weaker than most similar companies.
Has Hims & Hers Health, Inc.'s PosiPenta changed since last week?
Yes, it rose 19.81 points, from 22.15 to 41.96.
PositoAI is for research and education only and is not investment advice.